目前和新出现的性结肠炎生物标志物
Jan K Nowak1, Rahul Kalla2, Jack Satsangi3
1Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Expert review of molecular diagnostics
|November 7, 2023
概括
针对性结肠炎 (UC) 的个性化药物可以通过新的生物标志物得到改进. 研究突出了新的诊断,预后和治疗响应工具,以更好地管理UC.
科学领域:
- 生物标志物的发现和在炎症性肠病研究中的应用.
- 分子诊断和针对慢性疾病的个性化医学的进步.
背景情况:
- 性结肠炎 (UC) 是一种慢性疾病,需要终身治疗.
- 使用生物标志物的个性化护理策略可以提高UC患者的治疗结果.
研究的目的:
- 审查目前对于性结肠炎的生物标志物发现方式.
- 突出最近在UC的诊断,预后和治疗反应生物标志物的进展.
- 讨论新生物标志物在优化UC护理方面的潜力和挑战.
主要方法:
- 对生物标志物发现方式的审查,包括自身抗体,蛋白质,转录组学和代谢组学.
- 分析最近的生物标志物性能研究结果,使用AUC等指标.
- 对UC的既定和新兴生物标志物的讨论.
主要成果:
- 几种生物标志物在诊断 (例如,抗αvβ6抗体),疾病活性 (例如,便calprotectin) 和预后 (例如,转录组面板) 方面表现出高准确度 (AUC>0.90).
- 新兴证据包括自身抗体,蛋白质组板,转录基因特征,DNA甲基化和代谢障碍.
- 生物标志物正在探索用于预测治疗反应和识别亚临床疾病.
结论:
- 新型生物标志物有望通过个性化医疗优化性结肠炎护理.
- 在验证,简化和临床翻译复杂的生物标志物模型方面仍然存在挑战.
- 进一步的研究对于开发新工具和了解UC病原体至关重要.
更多相关视频
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
192
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
01:29Drugs for Treatment of Ulcerative Colitis in IBD
146
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
146
01:30Inflammatory Bowel Disease II: Crohn's Disease
259
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
259
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
136
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
136
01:29Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134